Synthetic nicotine variant sparks regulatory concerns across the EU

Marketed as an alternative to traditional nicotine, 6-methyl nicotine is drawing growing concern from public health authorities in countries across the European Union.

Also known as Metatine, this synthetic molecule, reportedly more addictive than tobacco-derived nicotine according to some studies, has quietly made its way into vaping products in Belgium, France and Sweden.

Over recent months, this relatively new synthetic compound has sparked increasing scrutiny from European public health bodies.

Unlock access
I'm already a subscriber
Author default picture

ECigIntelligence

This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization